4.2 Article

Extending lifespan by modulating the growth hormone/insulin-like growth factor-1 axis: coming of age

Journal

PITUITARY
Volume 24, Issue 3, Pages 438-456

Publisher

SPRINGER
DOI: 10.1007/s11102-020-01117-0

Keywords

Growth hormone; IGF-I; GHRKO mice; Longevity; Aging; Intervention testing program

Funding

  1. State of Ohio's Eminent Scholar Program
  2. NIH by the AMVETS [AG059779]
  3. Diabetes Institute at Ohio University

Ask authors/readers for more resources

Progress in aging research has allowed exploration of interventions to slow aging and extend lifespan. Studies on yeast, worms, flies, and mice have revealed cellular and molecular mechanisms related to longevity, with sex-specific success in extending lifespan observed in adult mice. Targeting non-overlapping aging-related pathways with a combination of interventions appears to be an effective approach to extend healthy lifespan in both sexes.
Progress made in the years of aging research have allowed the opportunity to explore potential interventions to slow aging and extend healthy lifespan. Studies performed in yeast, worms, flies and mice subjected to genetic and pharmacological interventions have given insight into the cellular and molecular mechanisms associated with longevity. Furthermore, it is now possible to effectively modulate pathways that slow aging at different stages of life (early life or at an adult age). Interestingly, interventions that extend longevity in adult mice have had sex-specific success, suggesting a potential link between particular pathways that modulate aging and sex. For example, reduction of the growth hormone (GH)/insulin-like growth factor-1 (IGF-1) axis at an adult age extends lifespan preferentially in females. Moreover, several postnatal dietary interventions tested by the 'Intervention Testing Program (ITP)' from the National Institute of Aging (NIA) have shown that while pharmacological interventions like rapamycin affect the IGF-1/insulin pathway and preferentially extend lifespan in females; dietary compounds that target other cellular pathways are effective only in male mice-indicating mutually exclusive sex-specific pathways. Therefore, a combination of interventions that target non-overlapping aging-related pathways appears to be an effective approach to further extend healthy lifespan in both sexes. Here, we review the germline and postnatal mouse lines that target the GH/IGF-1 axis as a mechanism to extend longevity as well as the dietary compounds that tested positive in the NIA program to increase lifespan. We believe that the interventions reviewed in this paper could constitute feasible combinations for an extended healthy lifespan in both male and female mice.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available